DNMT3A and cancer: Thus, the destabilization and mis-targeting reported in their study may operate under excessive UHRF1 overexpression, as they suggested, whereas the negative regulation of DNMT3A by UHRF1/2 reported in our study occurs in both regular and cancer cells.